Scientists test first shot against stomach bug
NCT ID NCT06630117
Summary
This study tested a new vaccine called V330 designed to protect against norovirus, a common stomach bug. Researchers gave the vaccine to 245 healthy adults aged 18-49 and 60-79 to check if it's safe and if it triggers the body to produce protective antibodies. This was an early safety study, so the main goal was to monitor for side effects rather than test how well it prevents illness.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
California Clinical Trials Medical Group managed by PAREXEL ( Site 0002)
Glendale, California, 91206, United States
-
QPS-MRA, LLC-Early Phase ( Site 0006)
South Miami, Florida, 33143, United States
-
Research Centers of America ( Hollywood ) ( Site 0004)
Hollywood, Florida, 33024, United States
-
Velocity Clinical Research, Hallandale Beach ( Site 0003)
Hallandale, Florida, 33009, United States
Conditions
Explore the condition pages connected to this study.